The first 3 groups of rats were administered with different concentrations of the pomegranate peel extract (500 [micro]g/mL, 250 [micro]g/mL, and 125 [micro]g/mL), the fourth group was administered with
nystatin (100000 U/kg/d), the fifth group was immunosuppressed and induced with oral candidiasis without treatment, the sixth group (control group) was not immunosuppressed and given only the pomegranate peel extract, and the seventh group was only immunosuppressed (table 1).
aureus (A) 1.25 10.4 [+ or -] 0.8 Methanol (a) 2.5 16.7 [+ or -] 1.2 5 21.3 [+ or -] 0.6 1.25 4.2 [+ or -] 0.5 Chloroform (b) 2.5 7.5 [+ or -] 0.9 5 12 [+ or -] 1.4 1.25 3.6 [+ or -] 1.1 Water (b) 2.5 7.1 [+ or -] 0.8 5 10.3 [+ or -] 1.5 Chloramphenicol 20 [+ or -] 0.5
Nystatin Zone of inhibition (mm) Gram-positive Gram-negative Solvent bacteria bacteria extract B.
albicans isolates from diabetic patients were highly susceptible to amphotericin B, fluconazole and
nystatin (100%) while 100% of them were resistant to econazole and 75% were resistant to miconazole.
Conclusion:
Nystatin (500,000 units) when combined with tissue conditioner was effective against candida albicans and can be an effective treatment in non-compliant DIS patients.
fumigatus were subjected to in-vitro antifungal drug sensitivity against Amphotericin-B, Clotrimazole,
Nystatin and Fluconazole.
A comparison of vaginal
nystatin and oral fluconazole for treating RVVC was performed in a recent study on 293 patients by a Chinese research group (23).
Nystatin in denture liners--an alternative treatment of denture stomatitis.
Our patient had used
nystatin cream, which is effective against Candida yeast infections, but not especially effective for Malassezia sp.
Several authors have analyzed
nystatin's physical and chemical characteristics (MICHEL, 1972).
In 1990, Dismukes and coworkers published a study of
nystatin for candidiasis hypersensitivity syndrome.
Although it was patented back in .1957 as the world's first antifungal, antibiotic
nystatin upstaged newer antifungal agents when used to treat vulvovaginal candidiasis caused by Candida glabrata in sequential, prospective clinical trials.